Rongtai Health released its 2026 interim report, with net profit attributable to the parent company of 112 million yuan, up 31.48% from the same period last year. Total operating revenue was 991 million yuan, up 22.29% year-on-year. Net cash flow from operating activities was negative 1.63 million yuan, down 101.81% year-on-year. The latest asset-liability ratio was 28.58%, gross margin was 29.31%, return on equity was 4.07%, and diluted earnings per share was 0.56 yuan.
Shanghai Rongtai Health TechNet profit up 31.48% and revenue up 22.29% in interim report.